{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:48:45Z","timestamp":1787006925621,"version":"build-2736575974"},"reference-count":71,"publisher":"Informa UK Limited","issue":"4","funder":[{"name":"funding associated"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Health Communication"],"published-print":{"date-parts":[[2025,3,21]]},"DOI":"10.1080\/10410236.2024.2363674","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T22:33:09Z","timestamp":1718145189000},"page":"702-712","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["\u201cSaving us to Death\u201d: Ideology and Communicative (Dis)enfranchisement in Misapplications of the 2016 CDC Opioid Prescribing Guidelines"],"prefix":"10.1080","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5202-4771","authenticated-orcid":false,"given":"Elizabeth A.","family":"Hintz","sequence":"first","affiliation":[{"name":"University of Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6698-8555","authenticated-orcid":false,"given":"Janelle","family":"Applequist","sequence":"additional","affiliation":[{"name":"University of South Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.11013"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/ct\/qty012"},{"key":"e_1_3_2_4_1","unstructured":"American Medical Association [AMA]. (2018). Report of reference committee B \u2013 annotated. https:\/\/www.ama-assn.org\/system\/files\/2018-11\/i18-refcomm-b-annotated.pdf"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.01.015"},{"key":"e_1_3_2_6_1","volume-title":"Broadcast pharmaceutical advertising in the United States: Primetime pill pushers","author":"Applequist J.","year":"2016","unstructured":"Applequist, J. (2016). Broadcast pharmaceutical advertising in the United States: Primetime pill pushers. Lexington Books."},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2024.116681"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssmqr.2022.100213"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10071353"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S367753"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1207\/s15327027hc1102_1"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/2159676X.2019.1628806"},{"issue":"1","key":"e_1_3_2_14_1","first-page":"1","article-title":"The misinformed & misguided prescription abuse prevention act: A response to delfino","volume":"1","author":"Capodilupo R.","year":"2023","unstructured":"Capodilupo, R., & Rich, J. J. (2023). The misinformed & misguided prescription abuse prevention act: A response to delfino. Yale Law and Policy Review, 1(1), 1\u201317. https:\/\/yalelawandpolicy.org\/inter_alia\/misinformed-misguided-prescription-abuse-prevention-act-response-delfino","journal-title":"Yale Law and Policy Review"},{"key":"e_1_3_2_15_1","unstructured":"Centers for Disease Control and Prevention [CDC]. (2016). About CDC\u2019s opioid prescribing guideline. https:\/\/www.cdc.gov\/opioids\/providers\/prescribing\/guideline.html"},{"key":"e_1_3_2_16_1","unstructured":"Centers for Disease Control and Prevention [CDC]. (2017). Prescription opioids. https:\/\/www.cdc.gov\/opioids\/basics\/prescribed.html"},{"key":"e_1_3_2_17_1","unstructured":"Centers for Disease Control and Prevention [CDC]. (2018). Process for updating the opioid prescribing guIdeline. https:\/\/www.cdc.gov\/opioids\/guideline-update-index.html"},{"key":"e_1_3_2_18_1","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention [CDC]. (2019). CDC advises against misapplication of the guideline for prescribing opioids for chronic pain. https:\/\/www.cdc.gov\/media\/releases\/2019\/s0424-advises-misapplication-guideline-prescribing-opioids.html","DOI":"10.1201\/9781315201108-117"},{"key":"e_1_3_2_19_1","unstructured":"Centers for Disease Control and Prevention [CDC]. (2020). Overdose deaths accelerating during COVID-19. https:\/\/www.cdc.gov\/media\/releases\/2020\/p1218-overdose-deaths-covid-19.html"},{"key":"e_1_3_2_20_1","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention [CDC]. (2022). CDC clinical practice guideline for prescribing opioids for pain \u2013 United States 2022. https:\/\/www.cdc.gov\/mmwr\/volumes\/71\/rr\/rr7103a1.htm","DOI":"10.15585\/mmwr.rr7103a1"},{"key":"e_1_3_2_21_1","unstructured":"Centers for Disease Control and Prevention [CDC]. (2023). Training for healthcare professionals. https:\/\/www.cdc.gov\/opioids\/healthcare-professionals\/training\/index.html"},{"key":"e_1_3_2_22_1","unstructured":"Centers for Disease Control and Prevention [CDC]. (2024a). Commonly used terms. https:\/\/www.cdc.gov\/opioids\/basics\/terms.html"},{"key":"e_1_3_2_23_1","unstructured":"Centers for Disease Control and Prevention [CDC]. (2024b). Prescription drug monitoring programs. https:\/\/www.cdc.gov\/drugoverdose\/pdmp\/index.html"},{"key":"e_1_3_2_24_1","unstructured":"Centers for Disease Control and Prevention [CDC]. (2024c). Process for the development of the 2022 clinical practice guideline for prescribing opioids for pain. https:\/\/www.cdc.gov\/opioids\/guideline-update\/index.html"},{"key":"e_1_3_2_25_1","unstructured":"Centers for Disease Control and Prevention [CDC]. (2024d). Understanding the epidemic. https:\/\/www.cdc.gov\/opioids\/basics\/epidemic.html"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/2050312119841823"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/24740527.2021.1881886"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/hcr\/hqad049"},{"key":"e_1_3_2_29_1","unstructured":"Don\u2019t Punish Pain Rally. (2017). About DPPR. https:\/\/dontpunishpainrally.com\/about-dppr\/"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.1464"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.16271"},{"key":"e_1_3_2_32_1","first-page":"79","volume-title":"Concepts in action: Conceptual constructionism","author":"Flemmen A. B.","year":"2018","unstructured":"Flemmen, A. B. (2018). Sensitizing concepts in action: Expanding the framework. In H. Leiulfsrud & P. Sohlberg (Eds.), Concepts in action: Conceptual constructionism (pp. 79\u201394). Brill."},{"key":"e_1_3_2_33_1","volume-title":"The constitution of society: Outline of the theory of structuration","author":"Giddens A.","year":"1984","unstructured":"Giddens, A. (1984). The constitution of society: Outline of the theory of structuration. Blackwell\/Polity Press."},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-770"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/10410236.2024.2304494"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/10410236.2023.2257942"},{"key":"e_1_3_2_37_1","first-page":"24","volume-title":"Stuart Hall: Critical dialogues in cultural studies","author":"Hall S.","year":"1996","unstructured":"Hall, S. (1996). The problem of ideology: Marxism without guarantees. In D. Morley & K. Chen (Eds.), Stuart Hall: Critical dialogues in cultural studies (pp. 24\u201345). Routledge."},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/23808985.2020.1843368"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/00909882.2023.2179417"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/23808985.2022.2064325"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/joc\/jqae002"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/hcr\/hqad004"},{"key":"e_1_3_2_43_1","volume-title":"Relieving pain in America: A blueprint for transforming prevention, care, education, and research","author":"Institute of Medicine [IOM]","year":"2011","unstructured":"Institute of Medicine [IOM]. (2011). Relieving pain in America: A blueprint for transforming prevention, care, education, and research. National Academies Press."},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-06254-7"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001411"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11019-021-10040-5"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002145"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2885.1991.tb00014.x"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/19312450701399388"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1080\/10646175.2018.1439423"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/0147-1767(85)90062-8"},{"key":"e_1_3_2_52_1","unstructured":"Llorente E. (2018). As doctors taper or end opioid prescriptions many patients driven to despair suicide. https:\/\/www.foxnews.com\/health\/as-opioids-become-taboo-doctors-taper-down-or-abandon-pain-patients-driving-many-to-suicide"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-05337-4"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2017.06.008"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1080\/10410236.2019.1625000"},{"key":"e_1_3_2_56_1","unstructured":"MAXQDA. (2022). Introducing MAXQDA 2020. https:\/\/www.maxqda.com\/new-maxqda-2020"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-00954-1"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-4-55"},{"key":"e_1_3_2_59_1","unstructured":"Reddit. (2024). \/r\/Chronicpain. https:\/\/www.reddit.com\/r\/ChronicPain\/"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1080\/10410236.2015.1020261"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1080\/10410236.2020.1837464"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-022-00447-5"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1080\/17538068.2020.1752982"},{"key":"e_1_3_2_64_1","unstructured":"SocialChamp. (2024). Important reddit stats you need to know in 2024. https:\/\/www.socialchamp.io\/blog\/reddit-stats\/"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002271"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1177\/00936502231184318"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1080\/10410236.2022.2137772"},{"key":"e_1_3_2_68_1","unstructured":"U.S. Drug Enforcement Administration [DEA]. (2024). Facts about fentanyl. https:\/\/www.dea.gov\/resources\/facts-about-fentanyl"},{"key":"e_1_3_2_69_1","unstructured":"U.S. Food and Drug Administration [FDA]. (2019). FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual individualized tapering. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-identifies-harm-reported-sudden-discontinuation-opioid-pain-medicines-and-requires-label-changes?utm_campaign=FDA%20MedWatch-Opioid%20Pain%20Medicines%3A%20Drug%20Safety%20Communication&utm_medium=email&utm_source=Eloqua"},{"key":"e_1_3_2_70_1","unstructured":"Vaglienti R. (2018). Overview of SB 273 2018 opioid reduction act. https:\/\/www.wvctsi.org\/media\/12920\/sb-273-opioid-reduction-act.pdf"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1080\/10410236.2022.2025702"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215148"}],"container-title":["Health Communication"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10410236.2024.2363674","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:23:52Z","timestamp":1777436632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10410236.2024.2363674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3,21]]}},"alternative-id":["10.1080\/10410236.2024.2363674"],"URL":"https:\/\/doi.org\/10.1080\/10410236.2024.2363674","relation":{},"ISSN":["1041-0236","1532-7027"],"issn-type":[{"value":"1041-0236","type":"print"},{"value":"1532-7027","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=hhth20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=hhth20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-06-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}